PDLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PDL BioPharma Inc's quarterly cash and cash equivalents increased from Jun. 2013 ($251.5 Mil) to Sep. 2013 ($319.6 Mil) but then declined from Sep. 2013 ($319.6 Mil) to Dec. 2013 ($94.3 Mil).
PDL BioPharma Inc's annual cash and cash equivalents declined from Dec. 2011 ($168.5 Mil) to Dec. 2012 ($131.2 Mil) and declined from Dec. 2012 ($131.2 Mil) to Dec. 2013 ($94.3 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
PDL BioPharma Inc Annual Data
PDL BioPharma Inc Quarterly Data